Cadrenal Therapeutics, Inc.

NasdaqCM:CVKD Stock Report

Market Cap: US$25.0m

Cadrenal Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CVKD?
Owner TypeNumber of SharesOwnership Percentage
Institutions900.00601%
Individual Insiders564,98537.7%
General Public931,69662.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 105.3%.


Top Shareholders

Top 9 shareholders own 37.75% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
28%
Quang Pham
418,334US$7.0m0%no data
4.43%
Miroslav Dornak
66,332US$1.1m0%no data
2.74%
John Murphy
40,986US$683.8k0%no data
2.23%
Matthew Szot
33,333US$556.1k0%no data
0.22%
Glynn Wilson
3,333US$55.6k0%no data
0.18%
Steven Zelenkofske
2,667US$44.5k0%no data
0.004%
The Vanguard Group, Inc.
60US$1.0k0%no data
0.0017%
Royal Bank of Canada, Banking & Securities Investments
25US$417.00%no data
0.00033%
Bank of America Corporation, Asset Management Arm
5US$82.40%no data